Abstract Introduction Primary leiomyosarcoma (LMS) of the breast is an exceptionally rare mesenchymal malignancy that accounts for <0.0006% of all breast neoplasms. Owing to its rarity and the nonspecific nature of conventional imaging, achieving an accurate preoperative diagnosis is often difficult. Case Presentation...
Asako Yamamoto, R. Watanuki, Junko Kikuchi et al.· Case Reports in Oncology· 0 citations
The results highlight the antitumor activity and manageable safety profile of E7389-LF, indicating the potential of E7389-LF as a 1L treatment for patients with HER2-negative breast cancer, warranting further study.
Hiroshi Ishiguro, Y. Miyoshi, H. Yasojima et al.· Breast Cancer Research· 0 citations
OBJECTIVE
Human epidermal growth factor receptor (HER) 3, encoded by the ERBB3 gene, transduces signals most effectively when dimerized with HER2. Although HER3 protein expression has been considered a poor prognostic factor in ovarian cancer, limited data exist on changes in HER3 protein expression and ERBB3 messenger...
K. Yokosu, Riu Yamashita, Satoshi Fujii et al.· Journal of Gynecologic Oncol...· 0 citations
Endometrial cancer (EC) is one of the most prevalent gynecological malignancies. EC is characterized by limited therapeutic options and a substantial unmet medical need, particularly in advanced or metastatic stages. Although a high prevalence of concurrent
PIK3CA
and
CTNNB1
mutations has been reported in patie...
Takehiro Nakao, R. Kamata, Hitoshi Saito et al.· Cell Death Discovery· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.